Cresco Labs Inc(CL-CN)
CSE

Today's Change
Delayed Last Update
Day Low1.0000
Day High1.0300
Open:1.0000
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Business Wire
Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA
Business Wire
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026
Business Wire
Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank
Business Wire
Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration
Business Wire
Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety
Business Wire
Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives
Business Wire
Cresco Labs Opens Sunnyside Aberdeen, Marking Second Ohio Dispensary Opening in a Month
Business Wire
Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients
Business Wire
Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026
Business Wire
Cresco Labs Opens Sunnyside Bridgeport, Expanding Access in the Ohio Valley
Business Wire
Cresco Labs Awarded Texas Medical Cannabis License
Business Wire
Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement
Business Wire
Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026
Business Wire
Cresco Labs Establishes At-the-Market Offering
Business Wire
Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida
Business Wire
Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry
Business Wire
Cresco Labs Launches Flagship Flower Brand in Germany
Business Wire
Cresco Labs Delivers Strong Q3, Maintains Market Leadership, and Unlocks New Growth Opportunities
Business Wire
Cresco Labs to Report Third Quarter 2025 Financial Results on November 5, 2025

Profile

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.